We are looking for young people at least 2 years of age but under 18 to join a Crohn’s disease (CD) clinical trial to help us discover more about treating Crohn’s disease (CD). If you are looking for a potential new treatment option for Crohn’s disease (CD) or ulcerative colitis (UC) (including associated symptoms such as rectal pain, iron deficiency, constant need to poop, malnutrition and/or joint pain), consider one of our trials. All eligible participants will receive no-cost study-related care and study medication. Your young people at least 2 years of age but under 18 may be eligible to take part.

Your child may be eligible to take part in the trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited so act quickly.

Is your child currently experiencing moderate to severe ulcerative colitis flare-ups? Local clinical research study is testing a potential new medication to see if it may reduce abdominal pain or cramping, mouth sores, diarrhea, chronic fatigue, and/or liver disease associated with moderate to severe ulcerative colitis.
If you’re concerned about how moderate to severe ulcerative colitis affects your child’s life, find out more about the clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

We are looking for young people at least 2 years of age but under 18 to join a Crohn’s disease research study to help us discover more about treating moderate to severe IBD. If you are looking for a potential new treatment option for moderate to severe IBD or Inflammatory bowel disease (including associated symptoms such as recurrent diarrhea, weight loss, cramps, weight loss and/or canker sores), consider one of our UC studies. All eligible participants will receive no-cost study-related care and study medication. Your young people at least 2 years of age but under 18 may be eligible to take part.

Your child may be eligible to take part in the UC studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

Is your child currently experiencing moderate to severe CD flare-ups? Local clinical research study is testing a potential new medication to see if it may reduce diarrhea with blood, blood in the stool, bloody stool, frequent fevers, and/or anemia associated with moderate to severe CD.
If you’re concerned about how moderate to severe CD affects your child’s life, find out more about the clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrolling for a limited time.

We are looking for young people aged 2 to 17 years to join a Crohn’s disease research study to help us discover more about treating Crohn’s and ulcerative colitis. If you are looking for a potential new treatment option for Crohn’s and ulcerative colitis or moderate to severe ulcerative colitis (including associated symptoms such as tiredness, kidney stones, rectal pain, frequent fevers and/or joint pain), consider one of our IBD clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your young people aged 2 to 17 years may be eligible to take part.

Your child may be eligible to take part in the IBD clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrolling for a limited time.

Is your child currently experiencing inflammatory bowel disease flare-ups? Local Crohn’s disease (CD) study is testing a potential new medication to see if it may reduce weight loss, loss of appetite, cramps, weight loss, and/or liver disease associated with inflammatory bowel disease.
If you’re concerned about how inflammatory bowel disease affects your child’s life, find out more about the Crohn’s disease (CD) study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to take part.

We are looking for young people at least 2 years of age but under 18 to join a Crohn’s disease clinical research study to help us discover more about treating moderate to severe IBD. If you are looking for a potential new treatment option for moderate to severe IBD or gastrointestinal disease (including associated symptoms such as chronic diarrhea, persistent diarrhea, cramps, frequent fevers and/or liver disease), consider one of our Crohn’s disease (CD) research. All eligible participants will receive no-cost study-related care and study medication. Your young people at least 2 years of age but under 18 may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease (CD) research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to take part.

Is your child currently experiencing Crohn’s and ulcerative colitis flare-ups? Local Crohn’s disease (CD) trial is testing a potential new medication to see if it may reduce bloody diarrhea, reduced appetite, cramps, chronic fatigue, and/or eye pain associated with Crohn’s and ulcerative colitis.
If you’re concerned about how Crohn’s and ulcerative colitis affects your child’s life, find out more about the Crohn’s disease (CD) trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child is eligible.

We are looking for children to join a CD clinical trial to help us discover more about treating Crohn’s and UC. If you are looking for a potential new treatment option for Crohn’s and UC or ulcerative colitis (UC) (including associated symptoms such as abdominal cramps, growth failure, rectal pain, chronic fatigue and/or joint pain), consider one of our Crohn’s disease studies. All eligible participants will receive no-cost study-related care and study medication. Your children may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child is eligible.

Is your child currently experiencing Crohn’s and ulcerative colitis flare-ups? Local medical research study is testing a potential new medication to see if it may reduce joint pain, loss of appetite, cramps, weight loss, and/or eye pain associated with Crohn’s and ulcerative colitis.
If you’re concerned about how Crohn’s and ulcerative colitis affects your child’s life, find out more about the medical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.